Subcutaneous abatacept for the treatment of rheumatoid arthritis
The efficacy, safety and tolerability of i.v. abatacept are well established in patients with active RA. A s.c. abatacept formulation is now available in some countries. Here, we review clinical data for s.c. abatacept. Six trials are presented (Phase II dose-finding study, ACQUIRE, ALLOW, ACCOMPANY...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Oxford University Press
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651617/ |